Accéder au contenu
Merck
  • Amiloride toxicity in the fission yeast Schizosaccharomyces pombe is released by thiamine and mutations in the thiamine-repressible gene car1.

Amiloride toxicity in the fission yeast Schizosaccharomyces pombe is released by thiamine and mutations in the thiamine-repressible gene car1.

Gene (1996-05-24)
C Niederberger, H Fankhauser, E Edenharter, M E Schweingruber
RÉSUMÉ

Amiloride (Am) inhibits growth in the fission yeast Schizosaccharomyces pombe. We show that the toxic effect of this drug is relieved by low concentrations of thiamine (Th) and that the pyrimidine moiety of the Th molecule is responsible for growth inhibition release. A putative membrane protein encoded by the car1 gene is the target for Am action. It is responsible for Am sensitivity and is involved in the utilization of Th and its biosynthetic precursor, 4-amino-5-hydroxymethyl-2-methylpyrimidine. Its expression is repressed by Th and is under the genetic control of the genes, thi1, tnr1, tnr2 and tnr3, which have previously been shown to be responsible for the transcriptional control of genes involved in the biosynthesis and dephosphorylation of Th.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Methyl-5-thiazoleethanol, ≥98%, FG
Sigma-Aldrich
4-Methyl-5-thiazoleethanol, 98%
Supelco
4-Methyl-5-thiazoleethanol, analytical standard